Find uplifting stories about heroes, innovations, and solutions
6082 results for "** lyme disease"
Pfizer and Valneva's experimental Lyme disease vaccine proved highly effective in Phase III trials, bringing hope to millions who love the outdoors. If approved, it would be the first Lyme vaccine available in two decades.
A University of Kentucky scientist is turning Lyme disease bacteria against itself in a promising new treatment approach. The breakthrough comes as tick-borne illnesses have jumped 128% nationwide since 2020.
The federal government just announced one of the most ambitious campaigns ever to fight Lyme disease, which affects nearly half a million Americans every year. New tick control programs, AI-powered diagnostics, and $2.5 million in innovation prizes aim to turn the tide on this growing health threat.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
An island where 15% of residents have contracted Lyme disease is trying something unprecedented: specially bred mice that can't spread the bacteria to ticks. MIT researchers believe these tiny helpers could break the disease cycle that's plagued Nantucket for decades.
After decades without a vaccine option, Pfizer's new Lyme disease vaccine showed over 70% effectiveness in preventing infection among 9,400 participants. The breakthrough could protect the 476,000 Americans infected annually from a disease that often leads to chronic arthritis and heart problems.
After decades without a Lyme vaccine, Pfizer's new candidate proved more than 70% effective at preventing the disease in a major clinical trial. The breakthrough brings hope to millions who face the threat of this debilitating illness every time they step outdoors.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
Two determined moms and Yale researchers solved a medical mystery that was crippling children across Connecticut. Their discovery led to treatments that now help nearly half a million Americans recover each year.
A promising new Lyme disease vaccine from Pfizer and Valneva could protect against nearly half a million annual U.S. infections. The shot targets bacteria inside ticks before they can infect people.
After more than 20 years without a Lyme disease vaccine in the U.S., Pfizer's new four-dose vaccine shows promising results that could protect millions from the most common tick-borne illness in America. The vaccine, tested across thousands of people in the U.S., Canada, and Europe, marks a hopeful step forward for outdoor enthusiasts and those living in high-risk areas.
For the first time ever, children and adults with Alexander disease have a treatment that attacks the root cause of their condition, not just the symptoms. The FDA's approval of zilganersen gives hope to families facing a disease that has always been fatal.
A groundbreaking treatment for Huntington's disease just cleared a major hurdle, bringing hope to 240,000 Americans affected by this devastating condition. The experimental therapy could become the first disease-modifying treatment for a disorder that has had none.
A doctor who survived a rare disease now uses artificial intelligence to find unexpected treatments that help patients like Kaila Mabus, who was told she might not survive. His AI system tests 75 million possible drug-disease combinations in minutes.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
Researchers discovered how to disguise healthy mitochondria so they can slip into diseased cells undetected, extending the lives of mice with a fatal genetic disorder. The breakthrough could one day help children born with rare mitochondrial diseases.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
University of Queensland researchers have developed a breakthrough drug that could transform Motor Neurone Disease from a terminal diagnosis into a manageable chronic condition within five years. The discovery unlocks a previously untargetable immune receptor that plays a key role in neurodegenerative diseases.
Showing 20 of 6082